Standout Papers

Myeloid-derived suppressor cells in cancer and cancer therapy 2024 2026168
  1. Myeloid-derived suppressor cells in cancer and cancer therapy (2024)
    Samantha Lasser, Feyza Gül Özbay Kurt et al. Nature Reviews Clinical Oncology

Immediate Impact

2 from Science/Nature 49 standout
Sub-graph 1 of 23

Citing Papers

Extracellular vesicles in tumor immunity: mechanisms and novel insights
2025 Standout
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
2025 Standout
7 intermediate papers

Works of Ihor Arkhypov being referenced

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
2023
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
2022
and 4 more

Author Peers

Author Last Decade Papers Cites
Ihor Arkhypov 365 263 207 11 602
Samantha Lasser 383 258 216 11 616
Andrew M. Leader 545 390 189 10 733
Petya Apostolova 350 150 180 16 634
Hannah H. Yan 366 340 227 13 640
Sergio Ortiz‐Espinosa 376 214 158 9 595
Elena García-Martínez 349 275 236 12 649
Samia Q. Khan 307 188 203 11 627
Valeria Mollica Poeta 383 388 233 7 729
Jenny Sprooten 373 310 245 12 632
Zhi-Chun Ding 356 323 243 14 732

All Works

Loading papers...

Rankless by CCL
2026